Oklo
OKLO
$0.00
+4.00%
Oklo Inc. is a pre-revenue developer of advanced fission power plants, operating within the regulated electric utility sector. The company is a disruptive technology player focused on commercializing its liquid metal fast reactor technology, known as the Aurora powerhouse, designed to produce up to 15 megawatts of electricity from both recycled and fresh nuclear fuel. The current investor narrative is dominated by its progress through the complex regulatory gauntlet, with recent news highlighting key approvals and selection for a Department of Energy program, which validates its technology but also underscores the highly speculative, long-duration nature of the investment as the company remains years away from generating its first commercial revenue.…
OKLO
Oklo
$0.00
Related headlines
Investment Opinion: Should I buy OKLO Today?
Rating: Hold. The core thesis is that Oklo is a highly speculative, binary option on future regulatory success, unsuitable for most investors but potentially warranting a small, risk-capital position for those with a multi-year horizon and high risk tolerance.
Supporting evidence includes the company's strong liquidity position (current ratio of 49.08), which provides a multi-year runway, and positive analyst sentiment (4 out of 6 ratings are Buy/Overweight). However, these are outweighed by the complete absence of revenue, accelerating EBITDA losses (from -$36.19M to -$57.10M quarter-over-quarter), and a valuation entirely disconnected from fundamentals (P/E of -99.39, EV/EBITDA of -88.59). The stock's 70% decline from its high suggests the initial speculative premium has largely evaporated, but it remains a pure bet on an uncertain future.
The two biggest risks are a definitive regulatory rejection and an inability to access capital markets before cash runs out. This Hold rating would upgrade to a Buy only upon receipt of a definitive, unconditional NRC license for commercial operation, providing a clear path to revenue. It would downgrade to a Sell if quarterly cash burn accelerates beyond $70 million without a corresponding major milestone, or if the stock breaks decisively below the $44.88 support level on high volume. Relative to any traditional financial metric, the stock is dramatically overvalued; relative to its speculative option value, it is fairly valued after the steep correction, but still carries extreme risk.
Sign up to view all
OKLO 12-Month Price Forecast
Oklo is a pure-play option on advanced nuclear regulatory success, not an investment in a operating business. The steep price correction has removed some froth, but the stock remains a high-risk, long-duration asset entirely dependent on future events. The neutral stance reflects the balance between a robust liquidity position and the complete lack of near-term fundamentals. The stance would turn bullish only upon receipt of a definitive commercial license, converting option value into tangible project value. It would turn bearish if the stock breaks key technical support at $44.88 on high volume, signaling a loss of all speculative interest.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oklo's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
5 analysts
Implied Upside
—
vs. current price
Analyst Count
5
covering this stock
Price Range
$0 - $0
Analyst target range
Insufficient analyst coverage available in the provided dataset to calculate a consensus price target or recommendation distribution. The institutional ratings data shows six firms with recent actions, including four Buy/Overweight ratings and two Neutral ratings as of March 2026, but no specific price targets are provided. The lack of quantifiable targets is typical for a recently listed, pre-revenue company like Oklo, leading to higher volatility and less efficient price discovery as the investment case is based on binary regulatory outcomes rather than near-term financial forecasts.
Bulls vs Bears: OKLO Investment Factors
The investment debate for Oklo is a stark clash between transformative long-term potential and near-term financial reality. The bear side currently holds stronger evidence, as the company's pre-revenue status, accelerating losses, and 70% price collapse from highs are concrete, present-tense facts. The bull case is entirely forward-looking, hinging on regulatory success years away. The single most important tension is the timing and certainty of regulatory approval for commercial operation versus the company's accelerating cash burn rate. If approval is delayed beyond the current cash runway, the stock could face a catastrophic dilution event or failure. Conversely, a clear, accelerated path to a license could reignite speculative fervor and drive a sharp rally.
Bullish
- Strong Balance Sheet & Liquidity: The company has a fortress-like balance sheet with a current ratio of 49.08 and minimal debt (debt-to-equity of 0.00098). This provides a multi-year runway to fund its development, evidenced by $296.22 million in common stock issued in Q4 2025, insulating it from near-term financing risk.
- Key Regulatory & DOE Progress: Recent news highlights critical regulatory approvals and selection for a Department of Energy program, validating its Aurora reactor technology. These milestones are essential for the company's long-term commercialization thesis and address key fuel supply bottlenecks.
- Massive Addressable Market & AI Tailwind: Oklo's modular nuclear technology targets the soaring energy demands of data centers and AI, as highlighted by Meta's 6.6-gigawatt nuclear power purchase agreement. This creates a multi-decade, multi-billion dollar revenue opportunity once commercialized.
- Analyst Sentiment Leaning Positive: Institutional ratings show four Buy/Overweight ratings versus two Neutral ratings, indicating professional investor confidence in the long-term story despite the lack of near-term financial metrics. This support can provide stability during volatile periods.
Bearish
- Pre-Revenue with Accelerating Losses: Oklo has $0 revenue and its operating losses are widening, with Q4 2025 EBITDA of -$57.1 million, up from -$36.19 million in Q3. This accelerating cash burn (-$115.38M TTM FCF) underscores the high cost and long timeline to commercialization.
- Extreme Valuation Disconnected from Fundamentals: With no revenue, traditional valuation metrics are inapplicable (PS ratio of 0). The $10.5 billion market cap is purely speculative, supported only by future option value, making the stock highly vulnerable to sentiment shifts and multiple compression.
- Sustained Technical Downtrend & Weakness: The stock is in a pronounced downtrend, down 34.24% over six months and 17.47% over the past month, severely underperforming the S&P 500. Trading 70% below its 52-week high and near support at $44.88, it exhibits classic 'falling knife' characteristics.
- Binary Regulatory Risk & Long Timeline: The investment thesis is a binary bet on successful NRC approval for commercial operation, a process measured in years. Any regulatory delay or rejection could collapse the stock price, as the company has no alternative revenue streams.
OKLO Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -10.84% and a more severe 6-month decline of -34.24%. Currently trading at $57.49, the price sits near the lower end of its 52-week range, approximately 12% above the 52-week low of $44.88 and 70% below the 52-week high of $193.84; this positioning suggests the stock is in a deep correction phase, potentially offering a value opportunity but also carrying significant risk as a 'falling knife' given the lack of fundamental revenue support. Recent momentum remains decisively negative, with the stock down 17.47% over the past month and 1.51% over the past three months, both figures starkly underperforming the S&P 500's gains of -0.08% and 12.0%, respectively, indicating severe relative weakness and no sign of a trend reversal. Key technical support is the 52-week low area around $44.88, while resistance is far above near the 52-week high of $193.84; a breakdown below support could signal a capitulation phase, while a sustained move above it would be a first step toward stabilization. The stock's beta of 1.113 indicates it is moderately more volatile than the broader market, which is notable given its pre-revenue, high-risk profile.
Beta
1.11
1.11x market volatility
Max Drawdown
-73.8%
Largest decline past year
52-Week Range
$45-$194
Price range past year
Annual Return
-1.4%
Cumulative gain past year
| Period | OKLO Return | S&P 500 |
|---|---|---|
| 1m | +9.5% | +0.7% |
| 3m | +13.3% | +15.1% |
| 6m | -26.5% | +9.7% |
| 1y | -1.4% | +25.0% |
| ytd | -21.4% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OKLO Fundamental Analysis
Oklo has no revenue, with its most recent quarterly report for Q4 2025 showing $0 in revenue, consistent with zero revenue across all provided quarterly statements; this underscores the company's status as a pre-commercial development-stage entity with its growth trajectory entirely forward-looking and dependent on successful regulatory approval and plant construction. The company is deeply unprofitable, reporting a net income of -$41.45 million and a gross profit of -$149 thousand for Q4 2025, with operating losses (EBITDA of -$57.1 million) widening sequentially from -$36.19 million in Q3 2025, indicating accelerating cash burn as it invests in development rather than a path toward near-term profitability. The balance sheet shows a fortress-like liquidity position with a current ratio of 49.08 and minimal debt (debt-to-equity of 0.00098), but it is burning significant cash, with trailing twelve-month free cash flow of -$115.38 million and an operating cash flow of -$33.43 million in Q4 2025; the company is funding this burn through equity issuance, as evidenced by $296.22 million in common stock issued during the last quarter, making it entirely dependent on external financing to sustain operations.
Quarterly Revenue
$0.0B
2025-12
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-115379000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OKLO Overvalued?
Given the company's negative net income and negative EBITDA, the primary valuation metric is the Price-to-Sales (PS) ratio, which is 0 due to the absence of revenue, making traditional multiples inapplicable and highlighting that the current $10.5 billion market cap is purely a bet on future commercialization. Peer comparison is not meaningful on a PS basis as the industry average is not provided and Oklo has no sales; the valuation is instead driven entirely by speculative option value on its technology and regulatory progress, disconnected from current financial metrics. Historically, the stock's own valuation ratios are extreme, with a trailing P/E of -99.39 and an EV/EBITDA of -88.59, but these figures are artifacts of deep losses; the more telling historical context is the stock's precipitous price decline from its 52-week high of $193.84, representing a 70% drawdown, which signals a massive repricing of the initial speculative euphoria post-listing toward a more risk-aware assessment of its lengthy timeline.
PE
-99.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -455x~0x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-88.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are extreme and center on Oklo's complete lack of revenue and accelerating cash burn. The company reported a net loss of -$41.45 million in Q4 2025, with operating losses (EBITDA) widening sequentially to -$57.1 million. Trailing twelve-month free cash flow is -$115.38 million, funded entirely by equity issuance ($296.22 million in Q4). This creates a fundamental dependency on external capital markets; any disruption in its ability to raise equity would threaten its existence. There is also concentration risk in its single technology (Aurora reactor) and regulatory pathway, with no diversified revenue streams to mitigate failure.
Market & Competitive Risks are pronounced due to Oklo's speculative valuation. With a market cap of $10.5 billion and no sales, the stock trades on pure option value, making it highly sensitive to shifts in risk appetite and interest rates. Its beta of 1.113 indicates it is more volatile than the market, and the 70% drawdown from its high shows how quickly sentiment can reverse. Competitive risks include other advanced nuclear and renewable technologies reaching commercialization faster. Macro risks are significant, as higher interest rates (referenced in recent news on inflation repricing rate cuts) compress the present value of distant future cash flows, directly hurting long-duration assets like Oklo.
The Worst-Case Scenario involves a critical regulatory setback from the NRC, combined with a tightening capital market that prevents further equity raises. This would force the company to severely curtail operations, leading to a collapse in its option value. The realistic downside is a retest and break below the 52-week low of $44.88, representing a -22% decline from the current $57.49. Given the stock's history and lack of fundamentals, a capitulation sell-off could drive it significantly lower, potentially matching its maximum drawdown of -73.83% from the high, which would imply a price near $50. An investor could realistically face a loss of 30-50% in such an adverse scenario.
FAQ
The key risks are severe and layered: 1) Binary Regulatory Risk: The company's entire future hinges on NRC approval; a denial or major delay could render the stock worthless. 2) Financial Risk: With accelerating losses (Q4 EBITDA -$57.1M) and no revenue, survival depends on continuous equity raises, leading to massive shareholder dilution. 3) Timeline Risk: Commercialization is likely many years away, during which macro conditions, technology, or competition could change unfavorably. 4) Market Risk: As a speculative asset with a beta of 1.113, it is highly sensitive to shifts in risk appetite and interest rates, prone to severe drawdowns like the current -73.83% from its high.
A 12-month forecast for OKLO is inherently volatile and news-driven. Our base case (50% probability) sees the stock trading between $50 and $70 as it makes incremental regulatory progress and raises dilutive capital. The bull case (20% probability), targeting $105-$130, requires a major regulatory breakthrough like a construction permit. The bear case (30% probability), targeting $30-$45, involves a regulatory setback or funding crisis. The most likely scenario is the base case, which assumes the lengthy, uncertain regulatory grind continues without a definitive near-term resolution, keeping the stock in a volatile, trendless state.
OKLO is impossible to value using traditional metrics like P/E (currently -99.39) or P/S (0), as it has no earnings or sales. Its market cap represents the speculative 'option value' the market assigns to its future commercialization potential. Relative to its own history, the stock is 70% below its high, suggesting the initial euphoria has faded. Compared to any fundamental benchmark, it is dramatically overvalued. The valuation implies the market expects a high probability of regulatory success and massive future revenue generation, a very optimistic assumption given the technical and regulatory hurdles remaining.
OKLO is not a 'good' stock to buy for the vast majority of investors seeking capital preservation or income. It is a highly speculative, binary bet suitable only for a small portion of a portfolio dedicated to high-risk, long-term venture-style investments. The stock has no revenue, is burning over $115 million in cash annually, and its entire $10.5 billion valuation depends on successful regulatory approval years away. For an investor with a 10-year horizon, deep expertise in nuclear regulation, and a high risk tolerance, a small position could be justified. For everyone else, it is a clear avoid.
OKLO is exclusively a long-term investment, but with a critical caveat: the 'long term' refers to a 5-10 year horizon required for potential commercialization, not a traditional 'buy and hold' equity. It is utterly unsuitable for short-term trading due to its extreme volatility (beta 1.113), lack of revenue-based catalysts, and sensitivity to regulatory news flow that is unpredictable. There is no dividend, and earnings visibility is zero. The minimum suggested holding period for an investor who believes in the thesis is 5 years, with the understanding that the position could go to zero before any payoff is realized.